Status:
TERMINATED
Viability Imaging in Volumetric Angiography (VIVA 1)
Lead Sponsor:
Medstar Health Research Institute
Conditions:
Myocardial Scarring
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The primary objective of this study is twofold: 1. To define inter-reader variability of myocardial viability imaging within the first pass and delayed enhancement cardiac CT perfusion imaging 2. To ...
Detailed Description
The presence of myocardial scar using radionuclide or magnetic resonance imaging techniques indicates myocardial segments with a reduced likelihood of functional recovery following myocardial revascul...
Eligibility Criteria
Inclusion
- Eligible patients will be adults, ages 18 and above with:
- Known CAD with prior MI based upon clinical history or electrocardiographic criteria
- Planned redo-surgical myocardial revascularization
- Referred for CT (and eligible) for pre-op substernal mapping/coronary artery evaluation
Exclusion
- Inability to provide informed consent
- Allergy to iodinated contrast media (unless pre-medicated with medical prophylaxis)
- Chronic kidney disease manifested by a serum creatinine \>1.5 mg/dL, an estimated creatinine clearance \<50 ml/kg/min or on dialysis
- Currently reporting or evaluated in NYHA class IV heart failure
Key Trial Info
Start Date :
June 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2013
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT01408134
Start Date
June 1 2011
End Date
February 1 2013
Last Update
March 29 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington Hospital Center
Washington D.C., District of Columbia, United States, 20010